Developer of small molecule therapies for hematological and solid tumors. The company is pioneering discoveries in small molecule and peptide ligand activation of blood stem cell progenitors and NK cells for the treatment of cancer.
← All startups
NK:IO
SeedDeveloper of small molecule therapies for hematological and solid tumors. The company is pioneering discoveries in small molecule and peptide ligand activation of blood stem cell progenitors and NK cells for the treatment of cancer.
About
Institutional investors
UkriCancer Research HorizonsParkwalkStart CodonUK Innovation Science & Seed FundMeltwind AdvisoryFuture Planet CapitalCambridge AngelsImperial College LondonCancer ResearchNovaterra
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.